Our preliminary studies investigating the mechanisms of chemotherapy resistance in ovarian cancer have shown increased S100A10 expression in chemotherapy-resistant disease compared to expression observed in the same patient tissue at diagnosis (Figure 3). This evidence concerns the gene S100A10 and ovarian carcinoma.